Fresenius Medical Care AG (FMCQF) Capital Expenditures (2009 - 2025)

Fresenius Medical Care AG (FMCQF) has 17 years of Capital Expenditures data on file, last reported at -$486.6 million in Q4 2025.

• In Q4 2025, Capital Expenditures fell 95.42% year-over-year to -$486.6 million; the TTM figure through Dec 2025 stood at -$1.1 billion (down 41.96% YoY), while the FY2025 annual figure was -$1.0 billion, down 42.96% from the prior year.
• Capital Expenditures eased to -$486.6 million in Q4 2025, from -$166.4 million in the prior quarter.
• Across five years, Capital Expenditures topped out at -$140.1 million in Q1 2024 and bottomed at -$486.6 million in Q4 2025.
• A 5-year average of -$208.9 million and a median of -$180.3 million in 2022 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2022 — Capital Expenditures soared 33.03% — and 2025, when it tumbled 95.42%.
• Year by year, Capital Expenditures stood at -$307.7 million in 2021, then soared by 33.03% to -$206.1 million in 2022, then fell by 24.78% to -$257.1 million in 2023, then advanced by 3.18% to -$249.0 million in 2024, then sank by 95.42% to -$486.6 million in 2025.
• The last three Capital Expenditures figures came in at -$486.6 million (Q4 2025), -$166.4 million (Q2 2025), and -$149.4 million (Q1 2025), per Business Quant data.

Peer Comparison